Suchergebnisse - "Chan, Arlene"

PubPharm (149)

1

AMEERA-3 : Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Tolaney, S. | Chan, A. | Petrakova, K. | +13

2

Adjuvant Dose Dense Chemotherapy in Patients With Obesity : Short-Term Toxicities and Breast Cancer Outcome

enthalten in: Clinical breast cancer | 2023

von Lomma, C. | Chih, H. | Chan, A.

3

Potential therapeutic role for pigment epithelium-derived factor in post-menopausal breast cancer bone metastasis

enthalten in: The Journal of pharmacy and pharmacology | 2023

von Brook, N. | Dharmarajan, A. | Chan, A. | +1

4

Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET) : A randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Holmes, F. | Moy, B. | Delaloge, S. | +25

5

Prognostic role of immune environment in luminal B early breast cancer

enthalten in: Cancer medicine | 2023

von Chan, A. | Gill, J. | Chih, H. | +1

6

Final findings from the CONTROL trial : Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Chan, A. | Ruiz-Borrego, M. | Marx, G. | +19

7

Pigment epithelium-derived factor downregulation in oestrogen receptor positive breast cancer bone metastases is associated with menopause

enthalten in: Molecular and cellular endocrinology | 2023

von Brook, N. | Gill, J. | Chih, H. | +4

8

Prognostic role of immune environment in luminal B early breast cancer

enthalten in: Cancer Medicine | 2023

von Chan, A. | Gill, J. | Chih, H. | +1

9

NFκB-Mediated Mechanisms Drive PEDF Expression and Function in Pre- and Post-Menopausal Oestrogen Levels in Breast Cancer

enthalten in: International journal of molecular sciences | 2022

von Brook, N. | Gill, J. | Dharmarajan, A. | +2

10

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases : Final Results From the Phase 3 ATTAIN Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Tripathy, D. | Tolaney, S. | Seidman, A. | +74

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]